XML 33 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Nature of Operations and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Franchisor Disclosure
The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three months ended March 31, 2026 and 2025:
Three Months Ended
March 31,
Franchised clinics:20262025
Clinics open at beginning of period885 842 
Opened during the period3 5 
Closed during the period(20)— 
Clinics in operation at the end of the period868 847 
Three Months Ended
March 31,
Company-owned or managed clinics:20262025
Clinics open at beginning of period75 125 
Sold during the period— (2)
Closed during the period— (1)
Clinics in operation at the end of the period75 122 
Total clinics in operation at the end of the period943 969 
Clinic licenses sold but not yet developed57 94 
Future clinic licenses subject to executed letters of intent53 52 
Schedule of Variable Interest Entities
VIE net income (including the management fee) for the three months ended March 31, 2026 and 2025, respectively, is included in Income from discontinued operations before income tax expense and Income tax expense from discontinued operations in the condensed consolidated income statements as follows:
Three Months Ended
March 31,
20262025
Income from discontinued operations before income tax$726,039 $387,287 
Income tax expense from discontinued operations182,369 103,412 
Net income$543,670 $283,875 
The carrying amount of the VIEs’ assets and liabilities is included in discontinued operations as of March 31, 2026 and December 31, 2025 in the condensed consolidated balance sheets as follows:
March 31,
2026		December 31,
2025
Discontinued operations current assets$994,138 $994,138 
Discontinued operations current liabilities6,198,944 6,079,903 
Schedule of Reconciliation of Allowance for Credit Losses
The following table provides a reconciliation of the activity related to our allowance for credit losses:
Allowance for
Credit Losses
Balance at December 31, 2024$220,893 
Bad debt expense recognized during the year286,232 
Write-off of uncollectible amounts(77,638)
Balance at December 31, 2025$429,487 
   Bad debt expense recognized during the period 85,216 
   Write-off of uncollectible amounts(2,600)
Balance at March 31, 2026$512,103 
Schedule of Impairment Losses and Disposal Gains and Losses Recorded in Income from Discontinued Operations As a result of our evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the agreed upon sales prices or the clinics’ estimated fair values, we recorded an estimated net loss on disposal, which is included in Income from discontinued operations before income tax expense in the condensed consolidated income statement as follows:
Three Months Ended
March 31,
20262025
Net loss on disposition or impairment related to discontinued operations$408,232 $982,934 
The following table shows a reconciliation of our impairment and disposal losses recorded in Income from discontinued operations before income tax expense for the three months ended March 31, 2026 and 2025:
Three Months Ended
March 31,
20262025
Impairment on assets held for sale
Assets held for sale$408,232 $982,934 
Loss on disposal of assets other than by sale
Property and equipment, net816 9,241 
Operating lease right-of-use asset6,484 192,083 
Gain on the sale of assets(37,768)(50,901)
Total net loss on disposition or impairment related to discontinued operations$377,764 $1,133,357 
The key components of Net income from discontinued operations that were included in our condensed consolidated income statements are as follows:
Three Months Ended March 31,
20262025
Revenues:
Revenues from company-owned or managed clinics$9,354,191 $16,906,350 
Total revenues9,354,191 16,906,350 
Cost of revenues:
IT cost of revenues6,181 6,172 
Total cost of revenues6,181 6,172 
Selling and marketing expenses1,007,302 1,892,746 
Depreciation and amortization7,757 26,386 
General and administrative expenses7,564,501 12,270,222 
Total selling, general and administrative expenses8,579,560 14,189,354 
Net loss on disposition or impairment from discontinued operations377,764 1,133,357 
Income from discontinued operations390,686 1,577,467 
Other expense, net11,973 238 
Income before income tax expense378,713 1,577,229 
Income tax expense from discontinued operations182,369 103,412 
Net income from discontinued operations$196,344 $1,473,817 
The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our condensed consolidated balance sheets:
March 31,
2026		December 31,
2025
ASSETS
Accounts receivable$275,679 $315,201 
Prepaid expenses and other current assets170,177 581,504 
Assets held for sale, net of valuation allowance20,083,666 20,051,965 
Property and equipment, net15,052 67,779 
Deferred tax assets (attributable to VIEs)994,138 994,138 
Deposits and other assets235,870 235,731 
Total assets, discontinued operations$21,774,582 $22,246,318 
LIABILITIES
Accounts payable$32,098 $83,503 
Accrued expenses2,934,669 2,519,433 
Payroll liabilities ($0.4 million and $0.6 million attributable to VIEs, respectively)
826,461 988,865 
Operating lease liability, current portion604,826 651,844 
Other current liabilities (attributable to VIEs)756,483 756,483 
Liabilities to be disposed of ($4.7 million and $4.7 million attributable to VIEs, respectively)
16,044,023 16,368,318 
Total liabilities, discontinued operations$21,198,560 $21,368,446 
The key components of cash flows from discontinued operations are as follows:
Three Months Ended March 31,
20262025
Significant operating and investing non-cash items:
Depreciation and amortization$7,757 $26,386 
Net loss on disposition or impairment377,764 1,133,357 
Capital expenditures:
Purchase of property and equipment— 66,656 
The principal components of the held for sale assets and liabilities to be disposed of as of March 31, 2026 and December 31, 2025 were as follows:
March 31, 2026December 31, 2025
Assets:
   Property and equipment, net
$4,496,729 $4,497,545 
   Operating lease right-of-use asset14,551,830 14,111,081 
   Intangible assets, net4,288,265 4,288,265 
   Goodwill3,482,718 3,482,718 
   Valuation allowance(6,735,876)(6,327,644)
Total assets held for sale, net$20,083,666 $20,051,965 
Liabilities:
   Operating lease liability, current and non-current$10,656,341 $11,065,542 
   Deferred revenue from company-owned or managed clinics5,387,682 5,302,776 
Total liabilities to be disposed of$16,044,023 $16,368,318 
Schedule of Earnings (loss) per Common Share
Three Months Ended
March 31,
20262025
Net income (loss) from continuing operations$1,102,791 $(506,021)
Net income from discontinued operations196,344 1,473,817 
Net income$1,299,135 $967,796 
Weighted average common shares outstanding - basic14,181,109 15,186,420 
Effect of dilutive securities:
Unvested restricted stock and stock options4,043 76,732 
Weighted average common shares outstanding - diluted14,185,152 15,263,152 
Income (loss) earnings per share:
Basic income (loss) earnings per share:
Continuing operations$0.08 $(0.03)
Discontinued operations0.01 0.10 
Net income per basic share$0.09 $0.06 
Diluted income (loss) earnings per share
Continuing operations$0.08 $(0.03)
Discontinued operations0.01 0.10 
Net income per diluted share$0.09 $0.06 
The following common stock equivalents were excluded from the computation of diluted earnings (loss) per share for the periods presented because including them would have been antidilutive:
Three Months Ended
March 31,
20262025
Stock options52,079 85,528